Ctxr sec filings

Author: ojpy

August undefined, 2024

WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Thu Dec 22 2024 Earnings Press Release 10-K Annual Report 10-K YoY Changes Citius …

d18rn0p25nwr6d.cloudfront.net

WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. WebJan 15, 2013 · Ticker: CTXR CIK: 1506251 Form Type: 10-K Annual Report Accession Number: 0001185185-13-000090 Submitted to the SEC: Tue Jan 15 2013 1:09:25 PM EST Accepted by the SEC: Tue Jan 15 2013 Period: Sunday, September 30, 2012 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark … highly rated badge facebook

Citius Pharmaceuticals, Inc. (CTXR) - finance.yahoo.com

WebDec 17, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-K Annual report for the fiscal year ending Monday, September 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Mon Dec 16 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebSEC Filings. All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. … WebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … small rice bugs

CTXR Short Interest Ratio and Volume (Citius Pharmaceuticals) …

WebCitius Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the CTXR U.S. Securities and Exchange Commission reporting information. WebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market ￻ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ highly rated banks near me highly rated back surgeons

"WebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio. " - Ctxr sec filings

Ctxr sec filings

CTXR 13F Hedge Fund and Asset Management Owners

WebInstitutional Ownership and Shareholders Citius Pharmaceuticals Inc (US:CTXR) has 94 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). … WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

Did you know?

WebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings...

WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024 WebSEC Filings for Citius Pharmaceuticals Inc (CTXR) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If …

WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. … WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

WebApr 6, 2024 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.

WebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News … highly rated basketball goalWebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... small rice cooker recipesWebApr 3, 2024 · ctxr The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 … highly rated barber shops in ballardWebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc highly rated bariatric surgeon in michiganWebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. small rice noodlesWebApr 6, 2024 · Citius Pharmaceuticals, Inc. SEC Filing - Quarterly Report (10-Q) February 10, 2024 SEC FilingsFri, Feb. 10 Citius Pharmaceuticals, Inc. SEC Filing - Proxy … small rich cakeWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024 highly rated bed in a box